Monoclonal antibody panels for acute leukemia and myelodysplastic syndrome diagnosis. Results of a co-operative quality control group.
The need for standardization criteria and result reproducibility in immunophenotyping hematological diseases has increased along with their clinical importance. Our group "Policentric Study Group on Immunological Markers", is composed of 40 laboratories. Its aim, over recent years, has been to find a standardized way of immunophenotypic analysis applicable to various hematological diseases. The objective of this study is to contribute to the debate concerning standardization of monoclonal antibody panels and immunophenotypic analysis procedures in acute leukemia (AL) and myelodysplastic syndrome (MDS), with the following targets: to improve interlaboratory reproducibility of the immunophenotyping data, and interpretative results; to study, with improved feasibility, correlation between immunophenotype and clinical or biological findings on a large number of AL and MDS cases; to verify the utility of the proposed monoclonal antibody panels for proper AL and MDS classification, and to detect minimal residual disease. In the field of AL and MDS our experience is based on about 1800 and 700 cases respectively analyzed over the last five years. Starting from these experiences and data of the literature we have elaborated the proposed panels of monoclonal antibodies and the methods of analysis. We have suggested a standardized immunophenotypic approach to study AL and MDS. In particular our work has focused on the gating strategy. This aims at drawing a gate of analysis having high purity and recovery, and on the choice of monoclonal antibody combinations for multiparametric analysis, particularly the normal antigen expression on each step of lineage differentiation or their clinically relevant aberrant expressions. A standardized criteria has become a necessary starting point in any kind of analytical process. In the field of acute leukemias and myelodysplastic syndromes the work of this polycentric group has focused on the pre-analytical and analytical steps to be taken in cytometric evaluation of hematological malignancies. The results obtained may contribute to reaching intra and inter-laboratory reproducibility.
Basso
G
G
Department of Pediatrics, University of Padova Medical School, Italy.
Bernasconi
P
P
Chianese
R
R
Crovetti
G
G
Garbaccio
G
G
Iavarone
A
A
Pautasso
M
M
Santagostino
A
A
Stacchini
A
A
D000208:Acute Disease; D000911:Antibodies, Monoclonal; D001773:Blood Cells / Q000276:immunology; D001854:Bone Marrow Cells / Q000276:immunology; D006801:Humans; D016130:Immunophenotyping / Q000592:standards; D007558:Italy; D007753:Laboratories / Q000592:standards; D007938:Leukemia / Q000175:diagnosis* / Q000276:immunology; D009190:Myelodysplastic Syndromes / Q000175:diagnosis* / Q000276:immunology; D011786:Quality Control; D015203:Reproducibility of Results
D000911:Antibodies, Monoclonal